Canada · Delayed Price · Currency is CAD CCL Industries Earnings Call Transcripts
Fiscal Year 2025
-
Sales and operating income grew in 2025, with record free cash flow and strong balance sheet improvements. RFID and direct-to-consumer segments are poised for growth, while margin expansion is not expected in 2026. Dividend increases and share buybacks highlight robust capital returns.
-
Q3 2025 saw 6.3% sales growth and 11% higher adjusted EPS, driven by strong CCL segment performance and improved margins. Free cash flow and liquidity were robust, while tariffs and supply chain volatility remain key risks.
-
Q2 2025 saw 4.8% sales growth and 8% higher adjusted EPS, with strong free cash flow and robust liquidity. Tariff-related supply chain disruptions impacted RFID and Checkpoint, while CCL and Innovia segments showed operational gains.
-
Q1 2025 saw 8.6% sales growth and record adjusted EPS, with strong free cash flow and robust liquidity. Segment performance was solid, though tariffs and U.S. back-to-school uncertainty pose risks, while new plant startups and global supply chain shifts offer opportunities.
Fiscal Year 2024
-
Q4 2024 saw 9% sales growth and a sharp rise in net income, driven by organic gains, acquisitions, and the absence of prior-year impairments. Segment performance was strong in most areas, with continued investment in capacity and a stable outlook amid macro uncertainties.
-
Q3 2024 saw 9.4% sales growth and 14.7% higher adjusted EPS, driven by organic gains, acquisitions, and strong RFID performance. Free cash flow and liquidity remain robust, with continued capital investment and share buybacks. RFID and Innovia segments show strong momentum.
-
Q2 2024 saw double-digit sales and operating income growth, record adjusted EPS, and robust free cash flow. Strong segment performance was led by CCL, Checkpoint, and Innovia, with continued investment and share buybacks. Outlook remains positive, with steady demand and benign FX.